{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-25-009755","form_type":"8-K","ticker":"NXL","cik":"0001527352","company_name":"Nexalin Technology, Inc.","filed_at":"2025-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.634450+00:00","generated_at":"2026-05-16T14:14:49.647140+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"medium","headline":"Nexalin releases December 2025 investor presentation; cash $4.4M, no debt, warrants expired","bullets":["Financial snapshot: Cash $4.4M, zero debt, 18.2M common shares, 22.3M fully diluted; warrants expired Sept 2025.","Gen-2 SYNC (15mA) in-clinic device and Gen-3 HALO at-home device with subscription model highlighted.","Regulatory progress: FDA De Novo strategy for Alzheimer's, insomnia; clearances in China, Brazil, Oman, Israel.","Clinical results claim 77% insomnia improvement, 74% depression improvement; Alzheimer's cognitive gains noted.","Go-to-market includes military TBI/PTSD advisory board with former NATO Supreme Commander and DoD official."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-25-009755","json":"https://secwatch.observer/filing/0001829126-25-009755.json","markdown":"https://secwatch.observer/filing/0001829126-25-009755.md","text":"https://secwatch.observer/filing/0001829126-25-009755.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625009755/0001829126-25-009755-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625009755/nexalintech_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T14:14:49.647140+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}